Kansas City, Mo (PRWEB) April 06, 2016
The JDRF Kansas City Chapter announced Kansas City Chiefs Chairman and CEO, Clark Hunt, and his wife, Tavia Hunt, will serve as Honorary Chairs for the JDRF Dream Gala on Saturday, May 21 at the Muehlebach Tower at the Downtown Kansas City Marriott. As Honorary Chairs, the Hunts will lead efforts to raise funds for research for type 1 diabetes.
In addition to chairing the Dream Gala, The Hunt Family Foundation is the presenting sponsor, “We are thrilled that Tavia and Clark Hunt have agreed to be Honorary Chairs for the 2016 JDRF Dream Gala,” says JDRF Kansas City Chapter’s Immediate Past Board President, Cathy Baier. “The Hunt Family Foundation does so much to make life better for people in our community, and we are honored that they chose to join us in the quest to create a world without type 1 diabetes.”
The JDRF Dream Gala raises more than $2 million to support type 1 diabetes research. The Dream Gala begins with a cocktail reception and silent auction at 5:30 p.m., followed by dinner, live auction and Fund A Cure at 7:30 p.m. The evening will conclude with live entertainment by The Michael Beers Band beginning at 10:00 p.m. Tickets are $350 per person and can be purchased online at jdrf.org/kansascity.
About the Hunt Family Foundation
The Hunt Family Foundation, formerly the Chiefs Children’s Fund, is a 501(c)(3) nonprofit organization established by the Hunt family in 1983 to support charitable agencies in the greater Kansas City community. The Foundation is committed to making a positive impact on those in need in the greater Kansas City community through philanthropy, programming and volunteerism and provides vital assistance to over 125 local charities each year.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents and adults with the disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. Since its founding in 1970, JDRF has awarded more than $1.6 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF's expenditures directly support research and research-related education.